Trial Profile
Role of Sildenafil for Fontan Associated Liver Disease (SiFALD) Study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Sildenafil (Primary)
- Indications Liver disorders
- Focus Pharmacodynamics
- Acronyms SiFALD
- 04 Oct 2019 Status changed from recruiting to completed.
- 18 May 2017 New trial record